- Home
- JAGX vs STBX Comparison
JAGX vs STBX Comparison
Compare JAGX & STBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- STBX
- Stock Information
- Founded
- JAGX 2013
- STBX 2019
- Country
- JAGX United States
- STBX Malaysia
- Employees
- JAGX 49
- STBX N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- STBX Advertising
- Sector
- JAGX Health Care
- STBX Consumer Discretionary
- Exchange
- JAGX Nasdaq
- STBX Nasdaq
- Market Cap
- JAGX 3.1M
- STBX N/A
- IPO Year
- JAGX N/A
- STBX 2022
- Fundamental
- Price
- JAGX $4.85
- STBX $0.18
- Analyst Decision
- JAGX
- STBX
- Analyst Count
- JAGX 0
- STBX 0
- Target Price
- JAGX N/A
- STBX N/A
- AVG Volume (30 Days)
- JAGX 37.8K
- STBX 2.8M
- Earning Date
- JAGX 03-31-2025
- STBX 04-08-2025
- Dividend Yield
- JAGX N/A
- STBX N/A
- EPS Growth
- JAGX N/A
- STBX N/A
- EPS
- JAGX N/A
- STBX N/A
- Revenue
- JAGX $11,689,000.00
- STBX $6,174,236.00
- Revenue This Year
- JAGX $18.18
- STBX N/A
- Revenue Next Year
- JAGX $40.06
- STBX N/A
- P/E Ratio
- JAGX N/A
- STBX N/A
- Revenue Growth
- JAGX 19.75
- STBX N/A
- 52 Week Low
- JAGX $4.41
- STBX $0.14
- 52 Week High
- JAGX $540.00
- STBX $4.13
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- STBX 40.45
- Support Level
- JAGX $4.41
- STBX $0.16
- Resistance Level
- JAGX $5.45
- STBX $0.32
- Average True Range (ATR)
- JAGX 0.95
- STBX 0.04
- MACD
- JAGX 0.00
- STBX 0.00
- Stochastic Oscillator
- JAGX 3.54
- STBX 9.49
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.